165 related articles for article (PubMed ID: 34915416)
1. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer.
Sheikh A; Md S; Kesharwani P
Biomed Pharmacother; 2022 Feb; 146():112530. PubMed ID: 34915416
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
[TBL] [Abstract][Full Text] [Related]
3. Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics.
Gholikhani T; Kumar S; Valizadeh H; Mahdinloo S; Adibkia K; Zakeri-Milani P; Barzegar-Jalali M; Jimenez B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430951
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticle-streptavidin conjugates for rapid and efficient screening of aptamer function in lateral flow sensors using novel CD4-binding aptamers identified through Crossover-SELEX.
Fellows T; Ho L; Flanagan S; Fogel R; Ojo D; Limson J
Analyst; 2020 Aug; 145(15):5180-5193. PubMed ID: 32567629
[TBL] [Abstract][Full Text] [Related]
5. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
Zhong Y; Zhao J; Li J; Liao X; Chen F
Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
[TBL] [Abstract][Full Text] [Related]
6. Chimeric aptamers in cancer cell-targeted drug delivery.
Kanwar JR; Roy K; Kanwar RK
Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.
Reinemann C; Strehlitz B
Swiss Med Wkly; 2014 Jan; 144():w13908. PubMed ID: 24395443
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
[TBL] [Abstract][Full Text] [Related]
9. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
10. A novel aptamer developed for breast cancer cell internalization.
Zhang K; Sefah K; Tang L; Zhao Z; Zhu G; Ye M; Sun W; Goodison S; Tan W
ChemMedChem; 2012 Jan; 7(1):79-84. PubMed ID: 22170627
[TBL] [Abstract][Full Text] [Related]
11. [DNA aptamers selection for breast cancer].
Zamay GS; Belayanina IV; Zamay AS; Komarova MA; Krat AV; Eremina EN; Zukov RA; Sokolov AE; Zamay TN
Biomed Khim; 2016 May; 62(4):411-7. PubMed ID: 27562994
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools.
Jo H; Ban C
Exp Mol Med; 2016 May; 48(5):e230. PubMed ID: 27151454
[TBL] [Abstract][Full Text] [Related]
13. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
[TBL] [Abstract][Full Text] [Related]
14. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
15. X-Aptamer Selection and Validation.
Lokesh GL; Wang H; Lam CH; Thiviyanathan V; Ward N; Gorenstein DG; Volk DE
Methods Mol Biol; 2017; 1632():151-174. PubMed ID: 28730438
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP/DOPE liposomes.
Song X; Ren Y; Zhang J; Wang G; Han X; Zheng W; Zhen L
Oncol Rep; 2015 Oct; 34(4):1953-60. PubMed ID: 26238192
[TBL] [Abstract][Full Text] [Related]
17. Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection.
Thiel WH; Bair T; Peek AS; Liu X; Dassie J; Stockdale KR; Behlke MA; Miller FJ; Giangrande PH
PLoS One; 2012; 7(9):e43836. PubMed ID: 22962591
[TBL] [Abstract][Full Text] [Related]
18. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
Liu M; Wang Z; Tan T; Chen Z; Mou X; Yu X; Deng Y; Lu G; He N
Theranostics; 2018; 8(20):5772-5783. PubMed ID: 30555580
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-aptamer bioconjugates for cancer targeting.
Farokhzad OC; Karp JM; Langer R
Expert Opin Drug Deliv; 2006 May; 3(3):311-24. PubMed ID: 16640493
[TBL] [Abstract][Full Text] [Related]
20. Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.
Zhou J; Li H; Zhang J; Piotr S; Rossi J
J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
